Key facts
- This page summarizes Jason Aryeh's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Jun 2026, 16:16.
Jason Aryeh - 23 Jun 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)
- Reporting relationship
- Director
- Issuer ticker
- OBIO
- Reported as of
- 23 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Jun 2026, 16:16:19 UTC
- Prior SEC filing
- 12 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Taylor, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jason Aryeh filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 25 Jun 2026.
Change
- Previous filing in this sequence was filed on 12 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001376960
Primary reporting owner
Aryeh Jason
- Relationship
- Director
- Address
- C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
- Signature
- /s/ Andrew Taylor, Attorney-in-Fact
- Signature date
- 25 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OBIO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +42,553
- Change %
- Price
- $0.000000*
- Shares after
- 42,553
- Date
- 23 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 42,553
- Exercise price
- $4.04
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock options will vest on the one year anniversary of June 23rd, 2026 (the "Grant Date"), subject to the Reporting Person's continuous service through such date.